Kerry Hunter

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

Kerry Hunter, Christian Hölscher · BMC Neuroscience · 2012 · 489 citations · Full text

Effects of the glucagon-like polypeptide-1 analogue (Val8)GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain

Stephen F.J. McGovern, Kerry Hunter, Christian Hölscher · Brain Research · 2012 · 42 citations

C57b/16 Mouse Brain, Developmental Biology, Progenitor Cell Proliferation +10

Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes

Nigel Irwin, Paula L. McClean, Steven Patterson et al. · Biological Chemistry · 2008 · 41 citations

Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice

Nigel Irwin, Kerry Hunter, Norma Frizzell et al. · Regulatory Peptides · 2008 · 39 citations

Obesity, Metabolic Syndrome, Background Exendin-4 Therapy +10

Comparison of independent and combined metabolic effects of chronic treatment with ( <scp>pGlu</scp> ‐Gln)‐ <scp>CCK</scp> ‐8 and long‐acting <scp>GLP</scp> ‐1 and <scp>GIP</scp> mimetics in high fat‐fed mice

Nigel Irwin, Kerry Hunter, I. A. Montgomery et al. · Diabetes Obesity and Metabolism · 2013 · 35 citations